 |
PDBsum entry 2i7k
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transcription
|
PDB id
|
|
|
|
2i7k
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Biochem Biophys Res Commun
358:435-441
(2007)
|
|
PubMed id:
|
|
|
|
|
| |
|
Solution structure of BRD7 bromodomain and its interaction with acetylated peptides from histone H3 and H4.
|
|
H.Sun,
J.Liu,
J.Zhang,
W.Shen,
H.Huang,
C.Xu,
H.Dai,
J.Wu,
Y.Shi.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
BRD7 is an important protein tightly associated with Nasopharyngeal carcinoma
(NPC). Overexpression of BRD7 inhibits NPC cell growth and cell cycle by
transcriptionally regulating the cell cycle related genes. BRD7 contains a
bromodomain that is found in many chromatin-associated proteins and in nearly
all known nuclear histone acetyltransferases (HATs) and plays an important role
in chromatin remodeling and transcriptional activation. Here, we report the
solution structure of BRD7 bromodomain determined by NMR spectroscopy, and its
binding specificity revealed by NMR titration with several acetylated histone
peptides. We find that BRD7 bromodomain contains the typical left-handed
four-helix bundle topology, and can bind with weak affinity to lysine-acetylated
peptides derived from histone H3 with K9 or K14 acetylated and from histone H4
with K8, K12 or K16 acetylated. Our results show that BRD7 bromodomain lacks
inherent binding specificity when binding to histones in vitro.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.C.Belkina,
and
G.V.Denis
(2012).
BET domain co-regulators in obesity, inflammation and cancer.
|
| |
Nat Rev Cancer,
12,
465-477.
|
 |
|
|
|
|
 |
J.Drost,
F.Mantovani,
F.Tocco,
R.Elkon,
A.Comel,
H.Holstege,
R.Kerkhoven,
J.Jonkers,
P.M.Voorhoeve,
R.Agami,
and
G.Del Sal
(2010).
BRD7 is a candidate tumour suppressor gene required for p53 function.
|
| |
Nat Cell Biol,
12,
380-389.
|
 |
|
|
|
|
 |
K.L.Yap,
and
M.M.Zhou
(2010).
Keeping it in the family: diverse histone recognition by conserved structural folds.
|
| |
Crit Rev Biochem Mol Biol,
45,
488-505.
|
 |
|
|
|
|
 |
E.I.Campos,
and
D.Reinberg
(2009).
Histones: annotating chromatin.
|
| |
Annu Rev Genet,
43,
559-599.
|
 |
|
|
|
|
 |
M.Thompson
(2009).
Polybromo-1: the chromatin targeting subunit of the PBAF complex.
|
| |
Biochimie,
91,
309-319.
|
 |
|
|
|
|
 |
M.Wu,
X.Li,
X.Li,
and
G.Li
(2009).
Signaling Transduction Network Mediated by Tumor Suppressor/Susceptibility Genes in NPC.
|
| |
Curr Genomics,
10,
216-222.
|
 |
|
|
|
|
 |
R.Sanchez,
and
M.M.Zhou
(2009).
The role of human bromodomains in chromatin biology and gene transcription.
|
| |
Curr Opin Drug Discov Devel,
12,
659-665.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |